Acute tubular necrosis primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 8: Line 8:
==Primary Prevention==
==Primary Prevention==
*Effective measures for the primary prevention of acute tubular necrosis include:
*Effective measures for the primary prevention of acute tubular necrosis include:
** Identifying individuals who are at risk for developing acute tubular necrosis. These include:
** Identifying individuals who are at risk for developing acute tubular necrosis.
*** Promptly treating conditions that can lead to decreased blood flow and/or decreased oxygen to the [[Kidney|kidneys]] can reduce the risk of acute tubular necrosis. These include:
*** Patients who are undergoing for major surgery such as cardiac or abdominal surgery
*** Patients who are undergoing for major surgery such as cardiac or abdominal surgery
*** Marked hypovolemia
*** Marked hypovolemia

Revision as of 17:44, 31 May 2018

Acute tubular necrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute tubular necrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute tubular necrosis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute tubular necrosis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute tubular necrosis primary prevention

CDC on Acute tubular necrosis primary prevention

Acute tubular necrosis primary prevention in the news

Blogs on Acute tubular necrosis primary prevention

Directions to Hospitals Treating Acute tubular necrosis

Risk calculators and risk factors for Acute tubular necrosis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]

Overview

Effective measures for the primary prevention of acute tubular necrosis include identification of individuals who are at high risk, maintain volume status and adequate renal perfusion by proper hydration, isotonic fluid administration, monitoring urine output and serum creatinine levels regular intervals to ensure normal renal function and avoiding or decreasing dose of nephrotoxins and contrast media.

Primary Prevention

  • Effective measures for the primary prevention of acute tubular necrosis include:
    • Identifying individuals who are at risk for developing acute tubular necrosis.
      • Promptly treating conditions that can lead to decreased blood flow and/or decreased oxygen to the kidneys can reduce the risk of acute tubular necrosis. These include:
      • Patients who are undergoing for major surgery such as cardiac or abdominal surgery
      • Marked hypovolemia
      • Severe hypotension
      • Acute pancreatitis
      • shock and sepsis
      • Chronic renal disease
      • Critically ill and hospitalized individuals
      • Diabetes mellitus
    • Monitor serum creatinine and urine output regularly in high-risk individuals.
    • Avoiding or decreasing daily dose of nephrotoxins[1]
    • Maintain volume status to ensure adequate renal blood flow by proper hydration or isotonic fluid administration.
    • Contrast media-induced acute tubular necrosis may be prevented with administration of isotonic saline along with radiocontrast substance.[2]

References

  1. Pazhayattil GS, Shirali AC (2014). "Drug-induced impairment of renal function". Int J Nephrol Renovasc Dis. 7: 457–68. doi:10.2147/IJNRD.S39747. PMC 4270362. PMID 25540591.
  2. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H (February 2002). "Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty". Arch. Intern. Med. 162 (3): 329–36. PMID 11822926.

Template:WH Template:WS